Intriguingly, amelioration of λ-MYC SS lymphoma growth in the Mertk−/− mice phenocopies mice deficient in Gals3 [galectin-3, see (24)], suggesting that MERTK and galectin-3 could provide different components in a common, pro-oncogenic mechanism. Here, MERTK is linked to lymphoma.